Replies to post #283105 on Amarin Corp Plc (AMRN)

[jessellivermore]

north40000..

Thanks for your learned opinion.. As a distinguished and long practicing Patent lawyer with years of specializing in Patent law maybe this guy will listen to you...

":>) JL

[cruyff22]

Thank you North and JL , hopefully this will be the last time it needs to be explained, but I guess some people like running into brick walls.

[Biobillionair]

North

When H enters the market sometime after today, particularly after mid-December 2022 with its generic Vascepa, tell us what you think Amarin will do, hypothetically speaking. How do you think that H escapes any charge of direct infringement in acting to bring its generic Vascepa to market?

The result of this appeal does not change the fact Amarin can take actions against any generic launch, this is why settlement is 100% likely.

The window for settlement is wide open. After this appeal is done...window is closed.

If court decides to rule on just briefs window is actively closing on generics “member”.

BB

[anfla]

There are no composition of matter claims - that’s obvious because it’s the same composition as Epadel.

They have some method claims for preventing oxidation, but obviously they aren’t required to make an FDA approved generic. In fact, Thero stated that some of the suppliers have patents for their own specific manufacturing scheme.

Obviously, the generics found suppliers not held by confidentiality agreements with Amarin to make their validation batches for FDA clearance. Now we have no idea how much supply they have - probably not that much. We also don’t know the terms of all the agreements with suppliers for Amarin. Thero seems to think they have a very strong hold on international supply, but we don’t know those details since the agreements are confidential.